Table 2.
Factor | Univariate (OR (95% CI)) | Multivariate (OR (95% CI)) |
---|---|---|
Disease extension (Proctitis/left-sided colitis vs. extensive colitis) | 2.23 (0.92–5.44) | –- |
Concomitant treatment with biologics or immunosuppressors (no vs pervious/active treatment) | 0.23 (0.069–0.79) | 0.35 (0.095–1.28) |
Global activity evaluation at baseline (mild vs. moderate) | 5.9 (1.17–19.8) | 4.6 (1.13–16.0) |
CI: confidence interval; OR: odds ratio.